Global Disease Control and Prevention Vaccine Market Insights and Forecast to 2028

Report ID: 1802443 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
1 Study Coverage
    1.1 Disease Control and Prevention Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Live-Attenuated
        1.2.3 Inactivated
        1.2.4 Recombinant Sub Unit and Toxoid
    1.3 Market by Application
        1.3.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pediatric Vaccine
        1.3.3 Adult Vaccine
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Disease Control and Prevention Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Disease Control and Prevention Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Disease Control and Prevention Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Disease Control and Prevention Vaccine Sales by Region
        2.4.1 Global Disease Control and Prevention Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Disease Control and Prevention Vaccine by Region (2023-2028)
    2.5 Global Disease Control and Prevention Vaccine Revenue by Region
        2.5.1 Global Disease Control and Prevention Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Disease Control and Prevention Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Disease Control and Prevention Vaccine Sales by Manufacturers
        3.1.1 Global Top Disease Control and Prevention Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Disease Control and Prevention Vaccine in 2021
    3.2 Global Disease Control and Prevention Vaccine Revenue by Manufacturers
        3.2.1 Global Disease Control and Prevention Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Disease Control and Prevention Vaccine Revenue in 2021
    3.3 Global Disease Control and Prevention Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Disease Control and Prevention Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Disease Control and Prevention Vaccine Sales by Type
        4.1.1 Global Disease Control and Prevention Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Disease Control and Prevention Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Disease Control and Prevention Vaccine Revenue by Type
        4.2.1 Global Disease Control and Prevention Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Disease Control and Prevention Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Disease Control and Prevention Vaccine Price by Type
        4.3.1 Global Disease Control and Prevention Vaccine Price by Type (2017-2022)
        4.3.2 Global Disease Control and Prevention Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Disease Control and Prevention Vaccine Sales by Application
        5.1.1 Global Disease Control and Prevention Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Disease Control and Prevention Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Disease Control and Prevention Vaccine Revenue by Application
        5.2.1 Global Disease Control and Prevention Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Disease Control and Prevention Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Disease Control and Prevention Vaccine Price by Application
        5.3.1 Global Disease Control and Prevention Vaccine Price by Application (2017-2022)
        5.3.2 Global Disease Control and Prevention Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Disease Control and Prevention Vaccine Market Size by Type
        6.1.1 North America Disease Control and Prevention Vaccine Sales by Type (2017-2028)
        6.1.2 North America Disease Control and Prevention Vaccine Revenue by Type (2017-2028)
    6.2 North America Disease Control and Prevention Vaccine Market Size by Application
        6.2.1 North America Disease Control and Prevention Vaccine Sales by Application (2017-2028)
        6.2.2 North America Disease Control and Prevention Vaccine Revenue by Application (2017-2028)
    6.3 North America Disease Control and Prevention Vaccine Market Size by Country
        6.3.1 North America Disease Control and Prevention Vaccine Sales by Country (2017-2028)
        6.3.2 North America Disease Control and Prevention Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Disease Control and Prevention Vaccine Market Size by Type
        7.1.1 Europe Disease Control and Prevention Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Type (2017-2028)
    7.2 Europe Disease Control and Prevention Vaccine Market Size by Application
        7.2.1 Europe Disease Control and Prevention Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Disease Control and Prevention Vaccine Revenue by Application (2017-2028)
    7.3 Europe Disease Control and Prevention Vaccine Market Size by Country
        7.3.1 Europe Disease Control and Prevention Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Disease Control and Prevention Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Disease Control and Prevention Vaccine Market Size by Type
        8.1.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Disease Control and Prevention Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Disease Control and Prevention Vaccine Market Size by Application
        8.2.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Disease Control and Prevention Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Disease Control and Prevention Vaccine Market Size by Region
        8.3.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Disease Control and Prevention Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Disease Control and Prevention Vaccine Market Size by Type
        9.1.1 Latin America Disease Control and Prevention Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Disease Control and Prevention Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Disease Control and Prevention Vaccine Market Size by Application
        9.2.1 Latin America Disease Control and Prevention Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Disease Control and Prevention Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Disease Control and Prevention Vaccine Market Size by Country
        9.3.1 Latin America Disease Control and Prevention Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Disease Control and Prevention Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Disease Control and Prevention Vaccine Market Size by Type
        10.1.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Disease Control and Prevention Vaccine Market Size by Application
        10.2.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Disease Control and Prevention Vaccine Market Size by Country
        10.3.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GSK
        11.1.1 GSK Corporation Information
        11.1.2 GSK Overview
        11.1.3 GSK Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GSK Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GSK Recent Developments
    11.2 Merck & Co., Inc
        11.2.1 Merck & Co., Inc Corporation Information
        11.2.2 Merck & Co., Inc Overview
        11.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck & Co., Inc Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Corporation Information
        11.3.2 Pfizer Overview
        11.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Pfizer Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Pfizer Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Corporation Information
        11.4.2 Sanofi Overview
        11.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sanofi Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sanofi Recent Developments
    11.5 AstraZeneca PLC
        11.5.1 AstraZeneca PLC Corporation Information
        11.5.2 AstraZeneca PLC Overview
        11.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 AstraZeneca PLC Recent Developments
    11.6 Sinovac Biotech Ltd
        11.6.1 Sinovac Biotech Ltd Corporation Information
        11.6.2 Sinovac Biotech Ltd Overview
        11.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Sinovac Biotech Ltd Recent Developments
    11.7 Astellas Pharma Inc
        11.7.1 Astellas Pharma Inc Corporation Information
        11.7.2 Astellas Pharma Inc Overview
        11.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Astellas Pharma Inc Recent Developments
    11.8 Serum Institute of India Pvt. Ltd
        11.8.1 Serum Institute of India Pvt. Ltd Corporation Information
        11.8.2 Serum Institute of India Pvt. Ltd Overview
        11.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Serum Institute of India Pvt. Ltd Recent Developments
    11.9 Daiichi Sankyo
        11.9.1 Daiichi Sankyo Corporation Information
        11.9.2 Daiichi Sankyo Overview
        11.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Daiichi Sankyo Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Disease Control and Prevention Vaccine Industry Chain Analysis
    12.2 Disease Control and Prevention Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Disease Control and Prevention Vaccine Production Mode & Process
    12.4 Disease Control and Prevention Vaccine Sales and Marketing
        12.4.1 Disease Control and Prevention Vaccine Sales Channels
        12.4.2 Disease Control and Prevention Vaccine Distributors
    12.5 Disease Control and Prevention Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Disease Control and Prevention Vaccine Industry Trends
    13.2 Disease Control and Prevention Vaccine Market Drivers
    13.3 Disease Control and Prevention Vaccine Market Challenges
    13.4 Disease Control and Prevention Vaccine Market Restraints
14 Key Findings in The Global Disease Control and Prevention Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Live-Attenuated
    Table 3. Major Manufacturers of Inactivated
    Table 4. Major Manufacturers of Recombinant Sub Unit and Toxoid
    Table 5. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Disease Control and Prevention Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Disease Control and Prevention Vaccine Sales by Region (2017-2022) & (K Units)
    Table 8. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2017-2022)
    Table 9. Global Disease Control and Prevention Vaccine Sales by Region (2023-2028) & (K Units)
    Table 10. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2023-2028)
    Table 11. Global Disease Control and Prevention Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2017-2022)
    Table 13. Global Disease Control and Prevention Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2023-2028)
    Table 15. Global Disease Control and Prevention Vaccine Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Disease Control and Prevention Vaccine Sales Share by Manufacturers (2017-2022)
    Table 17. Global Disease Control and Prevention Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 19. Disease Control and Prevention Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Disease Control and Prevention Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2021)
    Table 22. Disease Control and Prevention Vaccine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Disease Control and Prevention Vaccine Product Offered
    Table 24. Date of Manufacturers Enter into Disease Control and Prevention Vaccine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)
    Table 27. Global Disease Control and Prevention Vaccine Sales by Type (2023-2028) & (K Units)
    Table 28. Global Disease Control and Prevention Vaccine Sales Share by Type (2017-2022)
    Table 29. Global Disease Control and Prevention Vaccine Sales Share by Type (2023-2028)
    Table 30. Global Disease Control and Prevention Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Disease Control and Prevention Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Disease Control and Prevention Vaccine Revenue Share by Type (2017-2022)
    Table 33. Global Disease Control and Prevention Vaccine Revenue Share by Type (2023-2028)
    Table 34. Disease Control and Prevention Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Disease Control and Prevention Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)
    Table 37. Global Disease Control and Prevention Vaccine Sales by Application (2023-2028) & (K Units)
    Table 38. Global Disease Control and Prevention Vaccine Sales Share by Application (2017-2022)
    Table 39. Global Disease Control and Prevention Vaccine Sales Share by Application (2023-2028)
    Table 40. Global Disease Control and Prevention Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Disease Control and Prevention Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Disease Control and Prevention Vaccine Revenue Share by Application (2017-2022)
    Table 43. Global Disease Control and Prevention Vaccine Revenue Share by Application (2023-2028)
    Table 44. Disease Control and Prevention Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Disease Control and Prevention Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)
    Table 47. North America Disease Control and Prevention Vaccine Sales by Type (2023-2028) & (K Units)
    Table 48. North America Disease Control and Prevention Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Disease Control and Prevention Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)
    Table 51. North America Disease Control and Prevention Vaccine Sales by Application (2023-2028) & (K Units)
    Table 52. North America Disease Control and Prevention Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Disease Control and Prevention Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Disease Control and Prevention Vaccine Sales by Country (2017-2022) & (K Units)
    Table 55. North America Disease Control and Prevention Vaccine Sales by Country (2023-2028) & (K Units)
    Table 56. North America Disease Control and Prevention Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Disease Control and Prevention Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Disease Control and Prevention Vaccine Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Disease Control and Prevention Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Disease Control and Prevention Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Disease Control and Prevention Vaccine Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Disease Control and Prevention Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Disease Control and Prevention Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Disease Control and Prevention Vaccine Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Disease Control and Prevention Vaccine Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Disease Control and Prevention Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Disease Control and Prevention Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Disease Control and Prevention Vaccine Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Disease Control and Prevention Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Disease Control and Prevention Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Disease Control and Prevention Vaccine Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Disease Control and Prevention Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Disease Control and Prevention Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Disease Control and Prevention Vaccine Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Disease Control and Prevention Vaccine Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Disease Control and Prevention Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Disease Control and Prevention Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Disease Control and Prevention Vaccine Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Disease Control and Prevention Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Disease Control and Prevention Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Disease Control and Prevention Vaccine Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Disease Control and Prevention Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Disease Control and Prevention Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Disease Control and Prevention Vaccine Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Disease Control and Prevention Vaccine Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Disease Control and Prevention Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Disease Control and Prevention Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Disease Control and Prevention Vaccine Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 106. GSK Corporation Information
    Table 107. GSK Description and Major Businesses
    Table 108. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. GSK Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. GSK Recent Developments
    Table 111. Merck & Co., Inc Corporation Information
    Table 112. Merck & Co., Inc Description and Major Businesses
    Table 113. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Merck & Co., Inc Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Merck & Co., Inc Recent Developments
    Table 116. Pfizer Corporation Information
    Table 117. Pfizer Description and Major Businesses
    Table 118. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Pfizer Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Pfizer Recent Developments
    Table 121. Sanofi Corporation Information
    Table 122. Sanofi Description and Major Businesses
    Table 123. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Sanofi Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Sanofi Recent Developments
    Table 126. AstraZeneca PLC Corporation Information
    Table 127. AstraZeneca PLC Description and Major Businesses
    Table 128. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. AstraZeneca PLC Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. AstraZeneca PLC Recent Developments
    Table 131. Sinovac Biotech Ltd Corporation Information
    Table 132. Sinovac Biotech Ltd Description and Major Businesses
    Table 133. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Sinovac Biotech Ltd Recent Developments
    Table 136. Astellas Pharma Inc Corporation Information
    Table 137. Astellas Pharma Inc Description and Major Businesses
    Table 138. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Astellas Pharma Inc Recent Developments
    Table 141. Serum Institute of India Pvt. Ltd Corporation Information
    Table 142. Serum Institute of India Pvt. Ltd Description and Major Businesses
    Table 143. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Serum Institute of India Pvt. Ltd Recent Developments
    Table 146. Daiichi Sankyo Corporation Information
    Table 147. Daiichi Sankyo Description and Major Businesses
    Table 148. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Daiichi Sankyo Disease Control and Prevention Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Daiichi Sankyo Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Disease Control and Prevention Vaccine Distributors List
    Table 154. Disease Control and Prevention Vaccine Customers List
    Table 155. Disease Control and Prevention Vaccine Market Trends
    Table 156. Disease Control and Prevention Vaccine Market Drivers
    Table 157. Disease Control and Prevention Vaccine Market Challenges
    Table 158. Disease Control and Prevention Vaccine Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Disease Control and Prevention Vaccine Product Picture
    Figure 3. Global Disease Control and Prevention Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Live-Attenuated Product Picture
    Figure 4. Inactivated Product Picture
    Figure 5. Recombinant Sub Unit and Toxoid Product Picture
    Figure 6. Global Disease Control and Prevention Vaccine Market Share by Application in 2021 & 2028
    Figure 7. Pediatric Vaccine
    Figure 8. Adult Vaccine
    Figure 9. Disease Control and Prevention Vaccine Report Years Considered
    Figure 10. Global Disease Control and Prevention Vaccine Sales 2017-2028 (K Units)
    Figure 11. Global Disease Control and Prevention Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Disease Control and Prevention Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Disease Control and Prevention Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America Disease Control and Prevention Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Disease Control and Prevention Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Disease Control and Prevention Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Disease Control and Prevention Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Disease Control and Prevention Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Disease Control and Prevention Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Disease Control and Prevention Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Disease Control and Prevention Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Disease Control and Prevention Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Disease Control and Prevention Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Disease Control and Prevention Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Disease Control and Prevention Vaccine in the World: Market Share by Disease Control and Prevention Vaccine Revenue in 2021
    Figure 28. Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Disease Control and Prevention Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America Disease Control and Prevention Vaccine Revenue Share by Country (2017-2028)
    Figure 39. U.S. Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Disease Control and Prevention Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe Disease Control and Prevention Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Disease Control and Prevention Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Disease Control and Prevention Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Disease Control and Prevention Vaccine Sales Share by Country (2017-2028)
    Figure 73. Latin America Disease Control and Prevention Vaccine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Disease Control and Prevention Vaccine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Disease Control and Prevention Vaccine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Disease Control and Prevention Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. Disease Control and Prevention Vaccine Value Chain
    Figure 87. Disease Control and Prevention Vaccine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
Frequently Asked Questions
Disease Control and Prevention Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Disease Control and Prevention Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Disease Control and Prevention Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dyestuff for Cotton

Dyestuff for Cotton market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Epistaxis

Epistaxis market is segmented by Type and by Application. Players, stakeholders, and other partic ... Read More